IQV vs SGMT · P/E 23, rev $16.31B vs $403.2M cap
IQVIA Holdings Inc (IQV) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
SGMT does not have a complete income-statement cache yet.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the IQV and SGMT stock pages for the full models.
Not investment advice.